Our house believes that: The clipped lymph node is the true sentinel node after neoadjuvant chemotherapy in N+ patients
Breast. 2023 Oct 14;72:103592. doi: 10.1016/j.breast.2023.103592. Online ahead of print.ABSTRACTAxillary staging is an important prognostic factor in breast cancer, being sentinel lymph node biopsy (SLNB) the gold standard staging method in early stages. However, in clinically node positive (cN+) patients who converted to clinically node-negative (cN0) after primary systemic therapy (PST) the axillary staging method during surgery remains controversial. There are at least three validated methods: SLNB, targeted axillary dissection (TAD) and marking axillary nodes with radioactive iodine seeds (MARI) procedure. Our house believe that the biopsied and clipped lymph node could predict response to systemic treatment.PMID:37857128 | DOI:10.1016/j.breast.2023.103592
Source: Breast - Category: Cancer & Oncology Authors: Benigno Acea-Nebril Alejandra Garc ía-Novoa Alberto Bouz ón Alejandro Carlota D íaz Carballada Carmen Conde Iglesias Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Iodine | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy